News

Deal Announcements

CardioDx Scores $58 Million Venture Capital Round

Tuesday, August 28, 2012 5:33:00 AM PDT | VentureDeal

Palo Alto, California -- Genomic diagnostic company CardioDx has received $58 million in its sixth round of venture capital investment.

CardioDx develops genomic tests to aid in diagnosing and treating patients with cardiovascular disease.

The company was backed by a large syndicate of venture capital, private equity and corporate investors.

CardioDx said it would use the proceeds to support the commercial expansion of its gene expression test.

Email Page | Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

About VentureDeal

Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.

Learn More »

Home
Overview
Service Firms
Tech Entrepreneurs
Venture Investors

Services
Subscribe
Use Cases

FAQ
Terms of Use
Privacy Policy
Contact
Login